(Q46982023)

English

Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer

scientific article published on 25 September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer (English)

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

phase II clinical trial

0 references

4

object named as

Mark J Ratain

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

author name string

Theodore G Karrison

1

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

Michael L Maitland

2

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

Walter M Stadler

3

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

language of work or name

0 references

publication date

25 September 2007

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

99

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

19

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

1455-1461

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Can the pharmaceutical industry reduce attrition rates?

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

New designs for phase 2 clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Non-Randomized Controls in Cancer Clinical Trials

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Erlotinib in previously treated non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Strategies for optimizing combinations of molecularly targeted anticancer agents

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Model-based approaches to analysing incomplete longitudinal and failure time data.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Joint modelling of longitudinal measurements and event time data.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM158

21 January 2018

Identifiers

10.1093/JNCI/DJM158

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

1 reference

Europe PubMed Central

27 December 2017

http://europepmc.org/abstract/MED/17895472

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46982023&oldid=2140864165"